top of page
Download our new Healthcare M&A Report 2026
Healthcare M&A and Valuation
News and Insights


Infusion Therapy Valuation Multiples and M&A Trends 2026
The infusion therapy market has experienced significant growth in recent years, driven by the increasing prevalence of chronic diseases, advancements in healthcare technology and treatments, and the rising demand for home-based care. Infusion therapy, which involves the administration of medications or fluids directly into a patient’s bloodstream, is commonly used to treat conditions such as cancer, diabetes, infections, and autoimmune disorders. The shift toward outpatient a
2 days ago4 min read


Urgent Care Valuation Multiples and M&A Trends 2026
The U.S. urgent care industry has experienced significant growth over the past decade, driven by increasing patient demand for convenient, cost-effective healthcare solutions. Urgent care centers bridge the gap between primary care and emergency departments, offering walk-in services for non-life-threatening conditions such as minor injuries, infections, and respiratory illnesses. With over 14,000 centers nationwide as of 2023, the market has nearly doubled since 2014. Accord
6 days ago4 min read


Physical Therapy Valuation Multiples and M&A Trends 2026
The physical therapy industry is a large and steady-growing sub-segment within the healthcare industry, focused on improving mobility, managing pain, and enhancing overall quality of life for patients, often after a significant injury or surgical procedure. Services are provided in various settings including outpatient clinics, hospitals, post-acute facilities, and at-home, and address a wide range of conditions from orthopedic and neurological disorders to cardiopulmonary is
Apr 165 min read


Healthcare Revenue Cycle Valuation Multiples and M&A Trends 2026
The outsourced healthcare revenue cycle industry is a critical and fast-growing component of the healthcare system, responsible for managing the financial processes associated with generating revenue from payers for patient care. This includes coding, billing, claims submission, payment collection, and denial management. According to one source , the U.S. outsourced RCM market is expected to grow from $141.61 billion in 2024 to $272.78 billion by 2030, driven by increasing co
Apr 146 min read


Behavioral Health: Autism Services Valuation Multiples and M&A Trends 2026
Autism services are in high demand due to the rising prevalence of autism spectrum disorder (ASD) diagnoses and the increasing recognition of the benefits of early and ongoing intervention. Families seek evidence-based therapies, such as Applied Behavior Analysis (ABA), speech therapy, occupational therapy, and social skills programs, to improve functional outcomes and quality of life for individuals with autism. Public funding through Medicaid waivers, state programs, and pr
Apr 34 min read


Healthcare Staffing Valuation Multiples and M&A Trends 2026
The healthcare staffing industry connects medical facilities with skilled professionals to meet temporary and permanent staffing needs across a variety of roles. The sector includes traditional healthcare staffing services like travel nursing, per diem staffing, and locum tenens, but also includes a variety of firms focused on specialty staffing and outsourced niche services. The industry generally plays a critical role in addressing labor shortages, fluctuating patient deman
Mar 206 min read


Durable Medical Equipment Valuation Multiples and M&A Trends 2026
The durable medical equipment (DME) market has shown robust growth in recent years and is projected to continue expanding significantly through the next decade. Some segments face more headwinds than others, as some investors believe GLP-1 weight loss drugs may reduce demand for certain types of equipment. Grand View Research estimates that the global DME market, valued at approximately USD $208.5 billion in 2022, will reach $331.1 billion by 2030, with a compound annual gr
Mar 124 min read


Telemedicine M&A | Talkspace Acquired by UHS (~3.65x Revenue)
On March 9, 2026, Universal Health Services, Inc. (NYSE: UHS), one of the largest hospital and behavioral health care providers in the United States, announced a definitive agreement to acquire Talkspace, Inc. (NASDAQ: TALK), a leading teletherapy and digital mental health platform, at $5.25 per share in cash—representing a total enterprise value of approximately $835 million.
Mar 92 min read


Med Spa and Aesthetics Valuation Multiples and M&A Trends 2026
The med spa and aesthetic medicine segment of the overall general wellness industry has experienced significant growth over the past decade. Increasing demand for non-invasive aesthetic treatments, such as Botox, laser skin treatments, and body contouring, have propelled the sector, leading to an uptick in M&A. With the increasing popularity of GLP-1s, many med spas have diversified their services to include weight-loss management, another fast-growing market segment, while o
Mar 44 min read


Specialty Hospital M&A | Select Medical Taken Private by WCAS (~9.2x EBITDA / 0.72x Revenue)
On March 2, 2026, Select Medical Holdings Corporation (NYSE: SEM) announced a definitive agreement to be taken private by a consortium led by Executive Chairman and Co-Founder Robert A. Ortenzio, Senior Executive Vice President Martin F. Jackson, and private equity firm Welsh, Carson, Anderson & Stowe (WCAS) at $16.50 per share in cash, representing an enterprise value of approximately $3.9 billion.
Mar 22 min read


Occupational Medicine Valuation Multiples and M&A Trends 2026
The occupational health industry has experienced steady low- to mid- single-digit growth over the past several years and is projected to continue expanding steadily in the coming decade. According to one source , the global market is forecast to reach $5.94 billion by 2030, growing at a CAGR of 3.4% from 2024-2030, while another source forecasts a 5.86% CAGR from 2024-2032 for the U.S. market, specifically. Key Growth Drivers Key growth drivers for the industry include the fo
Feb 194 min read


Diagnostics M&A | Masimo Acquired by Danaher (~21.2x EBITDA / 6.5x Revenue)
On February 17, 2026, Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI), a leading specialty diagnostics provider of pulse oximetry and patient monitoring solutions, for $180 per share in an all-cash transaction representing a total enterprise value of approximately $9.9 billion, a premium of approximately 38% to Masimo's prior closing price.
Feb 172 min read


Revenue Cycle M&A | Tenet Acquires Remaining Conifer Health Stake (~14.0x EBITDA)
On February 2, 2026, Tenet Healthcare Corporation (NYSE: THC) announced the completion of a strategic transaction with CommonSpirit Health that returns Conifer Health Solutions to full Tenet ownership. Under the agreement, CommonSpirit will pay Tenet approximately $1.9 billion over three years, while Conifer will pay CommonSpirit approximately $540 million to redeem its 23.8% equity stake, effective January 1, 2026. The total deal value, including cash payments, balance sheet
Feb 22 min read


Surgical Hospital M&A | Oklahoma Spine Hospital Acquired by SSM Health (~7.0x EBITDA / 0.90x Revenue)
On February 2, 2026, Medical Facilities Corporation (TSX: DR) announced the sale of its 64% interest in Oklahoma Spine Hospital, LLC (OSH) to SSM Health, a nonprofit health system, for $46 million in cash. The purchase price implies a total 100% enterprise value of approximately $71.9 million. The transaction also included the concurrent sale of Medical Facilities' 51% interest in the Surgery Center of Newport Coast, LLC to Newport Orthopedic Institute for $19.5 million.
Feb 22 min read


Hospital System M&A | Nebraska Medicine / University of Nebraska Merger (~5.7x EBITDA / 0.63x Revenue)
On January 2, 2026, the University of Nebraska and Nebraska Medicine announced the completion of a historic transaction in which Clarkson, a legacy nonprofit health system, resigned its membership in Nebraska Medicine, effectively transferring its 50% governance interest to the University of Nebraska. The purchase price for Clarkson's 50% interest was $800 million, plus the assumption of outstanding debt and capital lease obligations of approximately $320.4 million as of June
Jan 62 min read


Quipt Taken Private by Kingswood and Forager (~4.7x EBITDA)
On December 15, 2025, existing shareholders Kingswood Capital Management and Forager Capital Management announced they reached a definitive agreement to fully acquire Quipt Home Medical Corp., a provider of durable medical equipment, home respiratory solutions, and connected home health services. Quipt’s offerings span oxygen therapy, sleep apnea management, non-invasive ventilation, and remote patient monitoring devices, servicing patients and payors through home health age
Dec 17, 20252 min read


Cencora Purchases Remainder of OneOncology (~19x EBITDA)
On December 15, 2025, Cencora, Inc. (NYSE: COR) announced a definitive agreement to acquire the majority of the outstanding equity interests it does not already own in OneOncology, a physician‑led national oncology platform that empowers independent cancer care practices, from private equity firm TPG and other shareholders. The purchase price was approximately $3.6 billion in cash plus retirement of ~$1.3 billion of existing corporate debt, implying total cash consideration
Dec 16, 20252 min read


Medical Manufacturing Technologies Acquired by Perimeter Solutions (~13.7x EBITDA)
On December 12 2025, Perimeter Solutions, Inc. (NYSE: PRM) entered into a definitive agreement to acquire Medical Manufacturing Technologies (MMT) from Arcline Investment Management for approximately $685 million in cash. MMT is a leading provider of highly engineered machinery, aftermarket consumables and services for the manufacturing of minimally invasive medical devices. The transaction positions Perimeter to diversify its offerings beyond its core fire‑safety and specia
Dec 13, 20252 min read


Intelerad Acquired by GE HealthCare (~28.4x EBITDA)
On November 20, 2025, GE HealthCare announced the acquisition of Intelerad, a global provider of enterprise imaging informatics and radiology IT solutions, in a transaction that further expands GE HealthCare’s digital imaging and clinical workflow capabilities. Intelerad’s platform includes radiology information systems (RIS), picture archiving and communication systems (PACS), advanced visualization, and cloud-enabled workflow tools serving hospitals, health systems, and i
Nov 22, 20252 min read


Thermo Fisher Acquires Clario (~19.7x EBITDA)
On October 29, 2025, Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings, Inc., a leading global provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg, Nordic Capital, Novo Holdings and Cinven for approximately $8.875 billion in cash at closing, with additional deferred and contingent payments of up to ~$525 million tied to future performance. The transaction, subject to customary re
Oct 30, 20252 min read
bottom of page